Expansion Plan
Expansion Readiness
| Criterion | Status | Target | Notes |
|---|---|---|---|
| Product-Market Fit in core market | Pending | D30 retention >35% | Must achieve before expansion |
| Unit economics proven | Pending | LTV:CAC >3:1 | Sustainable in core market |
| Operational processes established | Pending | Scalable systems | Can be replicated |
| Team capacity | Pending | Dedicated resources | Need bandwidth for expansion |
| Capital/runway | Pending | 12+ months | Fund expansion activities |
Geographic Expansion
Phase 1: English-Speaking
- USA (Core)
- UK
- Canada
- Australia
Phase 2: Localized
- Germany
- France
- Netherlands
Segment Expansion
Expand beyond initial target audience of adults 50+ managing 3+ daily medications for chronic conditions.
- VC-backed startups
- Enterprise innovation teams
- Consultants & advisors
- Business schools
- Agencies & studios
Business Model Expansion
Alternative expansion models:
- Licensing Model: License technology to other platforms or companies
- White-Label Model: Rebrandable version for resellers
- API/Platform Model: Open API for developers to build on top
12-Month Expansion Roadmap
- Months 1-4: Optimize Core
- Months 5-8: Phase 1 Geographic + Segment
- Months 9-12: Phase 2 Geographic + Enterprise
Revenue Projections by Market
| Timeframe | USA | UK/CA/AU | EU | Enterprise | Total |
|---|---|---|---|---|---|
| Month 6 | 80% | 15% | 0% | 5% | $10K/mo |
| Month 12 | 60% | 20% | 5% | 15% | $50K/mo |
| Month 18 | 50% | 20% | 10% | 20% | $150K/mo |
Expansion Risks & Mitigations
| Risk | Mitigation |
|---|---|
| Premature Expansion | Strict prerequisites before expansion |
| Resource Dilution | Dedicated expansion resources, automated for scale |
| Localization Quality | Professional translation, local review, start with English-first markets |
Expansion Success Metrics
- Revenue from expansion markets
- New market payback period
- Expansion market retention
- Localization ROI
- Segment expansion revenue